Evaluation of the immunogenicity and biological activity of the Citrobacter freundii Vi-CRM197 conjugate as a vaccine for Salmonella enterica serovar Typhi

Evaluation of the immunogenicity and biological activity of the Citrobacter freundii Vi-CRM197 conjugate as a vaccine for Salmonella enterica serovar Typhi

Item
http://www.wikidata.org/entity/Q34739155
Vaccines against invasive Salmonella disease: current status and future directionsSafety, immunogenicity and dose ranging of a new Vi-CRM₁₉₇ conjugate vaccine against typhoid fever: randomized clinical testing in healthy adultsSerum bactericidal assays to evaluate typhoidal and nontyphoidal Salmonella vaccines.Design of glycoconjugate vaccines against invasive African Salmonella enterica serovar TyphimuriumEngineering and preclinical evaluation of attenuated nontyphoidal Salmonella strains serving as live oral vaccines and as reagent strains.Differential Killing of Salmonella enterica Serovar Typhi by Antibodies Targeting Vi and Lipopolysaccharide O:9 AntigenStrain Selection for Generation of O-Antigen-Based Glycoconjugate Vaccines against Invasive Nontyphoidal Salmonella DiseaseDevelopment of a high-throughput method to evaluate serum bactericidal activity using bacterial ATP measurement as survival readoutO:2-CRM(197) conjugates against Salmonella Paratyphi A.A modification-specific peptide-based immunization approach using CRM197 carrier protein: Development of a selective vaccine against pyroglutamate Aβ peptides.Increasing rates of Salmonella Paratyphi A and the current status of its vaccine development.A scalable method for O-antigen purification applied to various Salmonella serovars.A cross-sectional seroepidemiological survey of typhoid fever in Fiji.A bivalent vaccine to protect against Streptococcus pneumoniae and Salmonella typhi.The influence of conjugation variables on the design and immunogenicity of a glycoconjugate vaccine against Salmonella Typhi.Role of Environmental Factors in Shaping Spatial Distribution of Salmonella enterica Serovar Typhi, Fiji.Structural and immunological characterization of derived recombinant CRM protein used as carrier in conjugate vaccines
P2860

Evaluation of the immunogenicity and biological activity of the Citrobacter freundii Vi-CRM197 conjugate as a vaccine for Salmonella enterica serovar Typhi

Item
http://www.wikidata.org/entity/Q34739155
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Evaluation of the immunogenici ...... monella enterica serovar Typhi
@ast
Evaluation of the immunogenici ...... monella enterica serovar Typhi
@en
Evaluation of the immunogenici ...... monella enterica serovar Typhi
@nl
type
label
Evaluation of the immunogenici ...... monella enterica serovar Typhi
@ast
Evaluation of the immunogenici ...... monella enterica serovar Typhi
@en
Evaluation of the immunogenici ...... monella enterica serovar Typhi
@nl
prefLabel
Evaluation of the immunogenici ...... monella enterica serovar Typhi
@ast
Evaluation of the immunogenici ...... monella enterica serovar Typhi
@en
Evaluation of the immunogenici ...... monella enterica serovar Typhi
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Evaluation of the immunogenici ...... monella enterica serovar Typhi
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P932